Dosage instructions for Poly-MVA

Take Poly-MVA on an empty stomach, at least 30 minutes before eating or two hours after eating
solid food. If the patient has difficulty with the taste of Poly-MVA, it may be taken with juice such
as cranberry, grape, prune or vegetable.
Use plastic, glass, or ceramic measuring devices and spoons, not metal ones, as metal ones may
adversely affect the taste of Poly-MVA.

Take your daily amount of Poly-MVA in divided doses if possible:
for example, 2 teaspoons, 4 times daily - three times before meals and once before bed. If you are
taking 1 tsp. daily or less, it's fine to take it all at once. If you have unresolvable scheduling conflicts
that prevent you from dividing your daily dosage, take it all at once.
As a longevity tonic or for prevention of disease, the adult dosage is ½ to 1 tsp. per day. One 8 oz.
bottle will last 7 to 14 weeks.

Adults with early stage diseases:

Loading dose: 8 tsp. daily in divided dosage - 2 tsp., 4 times daily, for one week. Then reduce to
4 tsp. daily - 2 tsp., twice daily, until the desired results are achieved. For maintenance of remission,
1-2 tsp. daily. Eight bottles are needed for the first three months.

Adults with late stage diseases:

8 tsp. daily in divided dosage - 2 tsp., 4 times daily for at least two months. Although the label on the
bottle references a "standard" dosage, physicians and patients alike have reported better overall
results on a dosage of 8 tsp. a day for at least two months. After that, consult with your physician,
and/or a qualified licensed alternative medical practitioner, and an AMARC consultant about the
feasibility of dosage reduction. Ten bottles are needed for the first two months.

Please Note:

If you are an adult in remission from a serious disease, and you are just now beginning to use
Poly-MVA, you are advised to follow the entire "Early Stage Protocol", starting with 8 tsp.
per day. DO NOT START WITH THE "MAINTENANCE DOSAGE".

Children with early stage diseases:
1 tsp. per 30 pounds of body weight until desired results achieved.

Children with late stage diseases:
1 tsp. per 20 pounds of body weight for at least two months before reducing the dosage.
After that, consult the child's physician, and/or qualified licensed alternative medical practitioner,
and an AMARC consultant about the feasibility of dosage reduction.

Recommendations

Poly-MVA and Antioxidants
Leave an interval of at least 6 hours between taking any but the most minimal amount of an antioxidant*
and Poly-MVA, to allow enough time for the antioxidant to leave the body before Poly-MVA is taken.
This guideline applies when taking more than 500 mg Vitamin C orally or intravenously. We recommend
that you take antioxidants early in the day, and wait six or more hours before taking Poly-MVA. If you
wish, you may "load up" on antioxidants at this time. This is strictly an individual choice. Remember
that Poly-MVA is itself a powerful antioxidant, which may reduce or eliminate your need for others.

*Note: The use of Co enzyme Q 10 is an exception to the guideline concerning the use of antioxidants.
Co Q 10 is synergistic with Poly-MVA, and sometimes enables Poly-MVA to access areas of the body
where there is little circulation. Some physicians recommend 400 mg daily in standard form, or 120 mg
daily of the concentrated "Q-Gel" form.
When using intravenous chelation therapy or oral chelation supplements to remove heavy metals or
arterial plaque from the body, leave an interval of at least 24 hours between using the chelates and
Poly-MVA: the chelates may chelate Poly-MVA.

The following may also render Poly-MVA ineffective:

1. Use of tobacco in any form.
2. Exposure to insecticides and herbicides.
3. Use of additional alpha lipoic acid, lipoic acid or thioctic acid.
4. Use of steroids in moderate to large amounts will significantly diminish the effectiveness of Poly-MVA.

Conditions for which Poly-MVA has been reported to be beneficial:

1. Malignancies of many kinds.*
2. Certain non malignant diseases and conditions: Lupus, fibromytosis, psoriasis, chronic fatigue
syndrome, multiple sclerosis, Alzheimer's.
3. Fatigue or lack of vitality.
4. Loss of appetite or weight.
5. Pain.
6. Maintenance remissions.
7. When radiation is indicated, post-radiation damage is often diminished with concurrent administration.
8. When radiation or chemotherapy is indicated, sometimes makes lower doses as effective as higher ones.

Contraindications:

None. Used as an adjuvant therapy, concurrently with primary conventional therapies such as
chemotherapy, radiation, and surgery, no contraindications are known at this time. Patients prone to
pleural effusion require careful monitoring by a physician, since fluid accumulation may increase
with the administration of Poly-MVA.

Effects that occasionally happen and are not a cause for alarm:

1. A cleansing reaction, also called a "detoxification reaction" or "healing crisis." This is caused by
Poly-MVA working too quickly. Reduce dosage until the symptoms disappear. Symptoms may include
rash, headache, unusual or strong body odors, diarrhea, fatigue, nausea, or a temporary worsening
of existing conditions. If someone gets a cleansing reaction, it is almost certain that Poly-MVA is
working for them.

2. A temporary rise in cancer markers due to a large cancer "die-off". In the book, An Alternative
Medicine Definitive Guide to Cancer, Dr. Jesse Stoff, M.D., an alternative medical doctor, is interviewed
regarding this subject. Dr. Stoff has observed that cancer markers do not always provide the best
indication of the specific character or relative aggressiveness of a cancer. With breast cancer, for
example, there are 4 different cancer markers, but it is rare to find a breast cancer that produces
more than 2 or 3 of them. "You can have a huge tumor sitting there and any one of these markers
can be well within normal range," Dr. Stoff says. There is also a less than adequate correlation
between cancer markers and the tumor mass. "You can have people with advanced metastatic
disease and only moderately elevated levels of cancer markers, and vice versa," Dr. Stoff says.
However, consistent correlations between tumor mass and cancer markers can serve as a rough
approximation of how well the battle is going for any one individual, he adds.

When the treatment activates the immune system to respond to the tumor cells, the cancer markers
will typically start showing a sudden rise or spike. This is because large amounts of proteins
(tumor antigens, or cancer markers) are released as the cancer cells begin to die. "The cancer
markers will go through the ceiling at this point," Dr. Stoff says. "One needs to be prepared for this
from a psychological point of view." If blood tests are done, cancer patients should realize that the
rise will be transient and that markers will drop precipitously as the immune system's scavenging cells, the
macrophages, sweep up the cancer cells' debris.

"The take-home lesson is that if you look at cancer markers only, you may get an inaccurate picture
of how the cancer is behaving at that time," says Dr. Stoff. "The test should be repeated later on to
ensure that the original reading is truly a spike, not an absolute, prolonged rise in the cancer markers."

Poly-MVA may act as a paramagnetic contrast agent:
*Attention Brain Cancer Patients

After several months of use, or after use at high dosages for a shorter time, Poly-MVA has sometimes
been known to act as a paramagnetic contrast agent in some X-ray and MRI scans. The prime concern
is that a shadow caused by Poly-MVA might be mistaken for a shadow from tumor progression.
In those cases where the patient is doing remarkably well and the only problematic finding is that the
MRI or X-ray shows enhancement, the physician is advised to do additional diagnostic studies.
Poly-MVA, a complex compound, contains a metal which vibrates when exposed to paramagnetic
radiation, and which can produce a radio-opaque halo/shadow, that if not carefully evaluated, leads
to a misreading of the X-ray or MRI. We therefore recommend that all patients taking Poly-MVA give
their physician this information so that the most accurate radiological evaluation can be achieved.
A CT scan may be preferable, thus avoiding the paramagnetic effect of the MRI and the palladium.
Patients and physicians may direct questions to our resident physician consultant, George Llamas,
MD at 800-649-2970.

Storage & Shelf Life:

It is not necessary to refrigerate Poly-MVA, but you may if you wish. Do not expose the Poly-MVA
bottle to direct sunlight since such exposure may affect the taste. Exposure to heat is not a problem.
There is no known end to the shelf life of Poly-MVA.

Protocols, Dosages, and the Number of Bottles Needed per Month:

Each 8 oz. bottle contains 48 teaspoons (236 cc) Poly-MVA. Dosages are weight-dependent:
dosage increases as weight increases. For the treatment of disease, (therapeutic dosages), use
under the supervision of a physician and/or a qualified licensed alternative medical practitioner.